90 related articles for article (PubMed ID: 3033465)
1. Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands.
Borea PA; Gilli G; Bertolasi V; Ferretti V
Mol Pharmacol; 1987 Apr; 31(4):334-44. PubMed ID: 3033465
[TBL] [Abstract][Full Text] [Related]
2. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors.
Im HK; Im WB; Hamilton BJ; Carter DB; Vonvoigtlander PF
Mol Pharmacol; 1993 Oct; 44(4):866-70. PubMed ID: 7901754
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding of beta-carbolines in mice: regional differences and correlation of occupancy to pharmacological effects.
Potier MC; Prado de Carvalho L; Dodd RH; Besselievre R; Rossier J
Mol Pharmacol; 1988 Aug; 34(2):124-8. PubMed ID: 2842651
[TBL] [Abstract][Full Text] [Related]
5. Molecular structure of Ro15-1788 and a model for the binding of benzodiazepine receptor ligands. Structural identification of common features in antagonists.
Codding PW; Muir AK
Mol Pharmacol; 1985 Aug; 28(2):178-84. PubMed ID: 2991738
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: recognition of active sites in receptor and modelling of interaction.
Gupta SP; Saha RN; Mulchandani V
J Mol Recognit; 1992 Jun; 5(2):75-80. PubMed ID: 1335277
[TBL] [Abstract][Full Text] [Related]
7. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
Araujo F; Ruano D; Vitorica J
J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
[TBL] [Abstract][Full Text] [Related]
8. Theoretical structure-activity studies of benzodiazepine analogues. Requirements for receptor affinity and activity.
Loew GH; Nienow JR; Poulsen M
Mol Pharmacol; 1984 Jul; 26(1):19-34. PubMed ID: 6087115
[TBL] [Abstract][Full Text] [Related]
9. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis.
Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM
J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648
[TBL] [Abstract][Full Text] [Related]
10. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship study of some benzodiazepine-receptor ligands having inverse agonist/antagonist and agonist actions.
Sharma RC; Ojha TN; Tiwari S; Singh P
Drug Des Discov; 1992; 9(2):135-43. PubMed ID: 1338366
[TBL] [Abstract][Full Text] [Related]
12. beta-Carbolines and benzodiazepine receptors: structure-activity relationships and pharmacologic activity.
Skolnick P; Williams EF; Cook JM; Cain M; Rice KC; Mendelson WB; Crawley JN; Paul SM
Prog Clin Biol Res; 1982; 90():233-52. PubMed ID: 6287491
[No Abstract] [Full Text] [Related]
13. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
Wafford KA; Whiting PJ; Kemp JA
Mol Pharmacol; 1993 Feb; 43(2):240-4. PubMed ID: 8381510
[TBL] [Abstract][Full Text] [Related]
14. Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.
Wafford KA; Bain CJ; Whiting PJ; Kemp JA
Mol Pharmacol; 1993 Aug; 44(2):437-42. PubMed ID: 8102787
[TBL] [Abstract][Full Text] [Related]
15. The nature of 1,4-benzodiazepines/receptor interactions.
Borea PA; Gilli G
Arzneimittelforschung; 1984; 34(6):649-52. PubMed ID: 6091702
[TBL] [Abstract][Full Text] [Related]
16. Axial chirality and affinity at the GABA(A) receptor of pyrimido[1,2-a][1,4]benzodiazepines and related compounds.
Lee S; Kamide T; Tabata H; Takahashi H; Shiro M; Natsugari H
Bioorg Med Chem; 2008 Nov; 16(21):9519-23. PubMed ID: 18829330
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies.
Huh KH; Delorey TM; Endo S; Olsen RW
Mol Pharmacol; 1995 Oct; 48(4):666-75. PubMed ID: 7476892
[TBL] [Abstract][Full Text] [Related]
18. Selective anxiolytics: are the actions related to partial "agonist" activity or a preferential affinity for benzodiazepine receptor subtypes?
Gee KW; Yamamura HI
Adv Biochem Psychopharmacol; 1983; 38():1-9. PubMed ID: 6142598
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
[TBL] [Abstract][Full Text] [Related]
20. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
